A Cancer Treatment Built for One Patient Just Cleared a 1,137-Person Trial
Merck and Moderna report the first successful late-stage trial of an mRNA cancer treatment. What the melanoma…
Africa’s Medicine Pledge Has Ambition, But Still Needs Accountability
Africa's pledge to make 60% of its medicines by 2040 has financing and political will. What it lacks is anyone…
To End Malaria, Delivery Must Become the Breakthrough
Malaria control has effective tools, but weak delivery systems continue to limit their impact.
Africa Wants to Make Its Own Medicines. Can Political Promises Become Production?
Africa wants to make more medicines locally. The harder task is building the markets to sustain them.
Public Health Careers Need a Better Map
Public health professionals are often told to find their niche. The deeper problem is that the field operates…
A signature is not consent: Africa’s fight over the new terms of U.S. health aid
Kenya, Ghana, and Zimbabwe show why the next test of global health partnership is data, fiscal risk, legal…
Health Workforce Shortages Are Coordination Failures
More programs and more students will not fix workforce shortages if education, clinical placement, hiring, and…
Malaria Drugs Are Losing Ground in Africa. The Response Is Too Slow
Artemisinin partial resistance is emerging in parts of Africa. The warning signs are technical, but the…
Pancreatic cancer vaccine clears an early scientific bar
A pancreatic cancer vaccine is meeting a higher bar, with early signs of durable immune activity and clinical promise.
Ghana’s next health reform will succeed or fail at first contact
The real test of Ghana’s free primary healthcare program is whether the system behind that promise can hold up.
